MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 185 filers reported holding MIRATI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,230,658 | -74.9% | 33,100 | -69.4% | 0.28% | -76.4% |
| Q4 2022 | $4,898,010 | +2464.4% | 108,100 | +8215.4% | 1.18% | +4121.4% |
| Q4 2021 | $191,000 | -98.5% | 1,300 | -98.2% | 0.03% | -96.8% |
| Q3 2021 | $12,615,000 | -71.3% | 71,300 | -72.2% | 0.89% | -40.0% |
| Q1 2021 | $43,939,000 | +273.6% | 256,500 | +378.9% | 1.48% | +185.5% |
| Q4 2020 | $11,762,000 | -87.9% | 53,557 | -90.9% | 0.52% | -92.7% |
| Q3 2020 | $97,563,000 | +469.7% | 587,557 | +291.7% | 7.06% | +418.0% |
| Q2 2020 | $17,126,000 | +49.6% | 150,000 | +0.7% | 1.36% | +58.3% |
| Q1 2020 | $11,446,000 | -40.3% | 148,900 | 0.0% | 0.86% | -72.3% |
| Q4 2019 | $19,187,000 | – | 148,900 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |